Nitric oxide levels in plasma and fibroblast cultures of psoriasis vulgaris patients.
Zalewska
Anna
A
Wyczółkowska
Janina
J
Narbutt
Joanna
J
Sysa-Jedrzejowska
Anna
A
D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D002460:Cell Line; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D009569:Nitric Oxide / Q000097:blood* / Q000378:metabolism; D011565:Psoriasis / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D013373:Substance P / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D009569:Nitric Oxide; D013373:Substance P; D014660:Vasoactive Intestinal Peptide